checkAd

    SHAREHOLDER ALERT  1937  0 Kommentare Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Medbox, Inc. of Class Action Lawsuit and Upcoming Deadline - MDBX - Seite 3

    Meanwhile, shares of Medbox fell $1.50 per share from their October 31, 2014 closing price of $13.95 per share, or 10.8%, to close at $12.45 on November 3, 2014. Shares fell another $2.75 per share on November 5, 2014 as the financial media reported on the ensuing SEC investigation and the market impacted the full import of the disclosures.

    Then, on November 7, 2014, Medbox filed a Current Report on Form 8-K with the SEC stating the November 3, 2014 press release, which quoted Defendant Mehdizadeh, had not been "authorized by Medbox."

    On December 30, 2014, before the opening of trading, Medbox issued a press release disclosing that it would be forced to restate the past five quarters of financial reports and potentially its "financial statements for 2012 and for the first two quarters of 2013... as well." The Company further disclosed that the earnings restatement had triggered a default on its debt covenants that had forced it to seek a forbearance from lenders. The release stated that the "steps [being taken were] part of the continued initiative of [Medbox's] new board of directors and new management team to implement better controls and emphasize transparency."

    On this news, shares of Medbox fell $0.81 per share, or approximately 12.67%, to close at $5.58 per share on December 31, 2014.

    The Pomerantz Firm, with offices in New York, Chicago, Florida, and San Diego, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

    CONTACT:
    Robert S. Willoughby
    Pomerantz LLP
    Email Contact

    Seite 3 von 3




    Verfasst von Marketwired
    SHAREHOLDER ALERT Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Medbox, Inc. of Class Action Lawsuit and Upcoming Deadline - MDBX - Seite 3 NEW YORK, NY--(Marketwired - Feb 27, 2015) - Pomerantz LLP announces that a class action lawsuit has been filed against Medbox, Inc. ("Medbox" or the "Company")(OTCBB: MDBX) and certain of its officers. The class action, filed in United States …

    Schreibe Deinen Kommentar

    Disclaimer